{"id":"https://openalex.org/W4396554064","doi":"https://doi.org/10.46542/pe.2024.243.5156","title":"Pinostrobin and its derivatives as novel anti-breast cancer agents against human oestrogen receptor alpha: In silico studies of ADMET, docking, and molecular dynamics","display_name":"Pinostrobin and its derivatives as novel anti-breast cancer agents against human oestrogen receptor alpha: In silico studies of ADMET, docking, and molecular dynamics","alternate_titles":[],"publication_year":2024,"publication_date":"2024-05-01","ids":{"openalex":"https://openalex.org/W4396554064","doi":"https://doi.org/10.46542/pe.2024.243.5156"},"language":"en","primary_location":{"id":"doi:10.46542/pe.2024.243.5156","doi":"https://doi.org/10.46542/pe.2024.243.5156","is_oa":true,"landing_page_url":"http://dx.doi.org/10.46542/pe.2024.243.5156","pdf_url":null,"source":{"id":"https://openalex.org/S151451544","display_name":"Pharmacy Education","issn_l":"1560-2214","issn":["1560-2214","1477-2701"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacy Education","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4396554064"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://dx.doi.org/10.46542/pe.2024.243.5156","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056320700","display_name":"Delis Susilawati","orcid":"https://orcid.org/0009-0006-3521-5572","observed_orcids":["https://orcid.org/0009-0006-3521-5572"]},"institutions":[{"id":"https://openalex.org/I205133468","display_name":"Universitas Airlangga","ror":"https://ror.org/04ctejd88","country_code":"ID","type":"education","lineage":["https://openalex.org/I205133468"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Delis Susilawati","raw_affiliation_strings":["Masters Programme of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia"],"raw_orcid":"https://orcid.org/0009-0006-3521-5572","affiliations":[{"raw_affiliation_string":"Masters Programme of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia","institution_ids":["https://openalex.org/I205133468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054099536","display_name":"Tri Widiandani","orcid":"https://orcid.org/0000-0002-0156-6095","observed_orcids":["https://orcid.org/0000-0002-0156-6095"]},"institutions":[{"id":"https://openalex.org/I205133468","display_name":"Universitas Airlangga","ror":"https://ror.org/04ctejd88","country_code":"ID","type":"education","lineage":["https://openalex.org/I205133468"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Tri Widiandani","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia & Research Group of Drug Development, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia"],"raw_orcid":"https://orcid.org/0000-0002-0156-6095","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia & Research Group of Drug Development, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia","institution_ids":["https://openalex.org/I205133468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110755286","display_name":"Siswandono Siswodihardjo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205133468","display_name":"Universitas Airlangga","ror":"https://ror.org/04ctejd88","country_code":"ID","type":"education","lineage":["https://openalex.org/I205133468"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Siswandono Siswodihardjo","raw_affiliation_strings":["Department of Pharmaceutical Sciences\u00a0, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia & Research Group of Drug Development, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences\u00a0, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia & Research Group of Drug Development, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia","institution_ids":["https://openalex.org/I205133468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054679810","display_name":"Suzana Suzana","orcid":"https://orcid.org/0000-0003-4066-2714","observed_orcids":["https://orcid.org/0000-0003-4066-2714"]},"institutions":[{"id":"https://openalex.org/I205133468","display_name":"Universitas Airlangga","ror":"https://ror.org/04ctejd88","country_code":"ID","type":"education","lineage":["https://openalex.org/I205133468"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Suzana Suzana","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia & Research Group of Drug Development, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia & Research Group of Drug Development, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia","institution_ids":["https://openalex.org/I205133468"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101978220","display_name":"Bambang Tri Purwanto","orcid":"https://orcid.org/0000-0002-4868-7230","observed_orcids":["https://orcid.org/0000-0002-4868-7230"]},"institutions":[{"id":"https://openalex.org/I205133468","display_name":"Universitas Airlangga","ror":"https://ror.org/04ctejd88","country_code":"ID","type":"education","lineage":["https://openalex.org/I205133468"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Bambang Tri Purwanto","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia & Research Group of Drug Development, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia & Research Group of Drug Development, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia","institution_ids":["https://openalex.org/I205133468"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I205133468"],"apc_list":null,"apc_paid":null,"fwci":0.5685,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.59031328,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"24","issue":"3","first_page":"51","last_page":"56"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pinostrobin","display_name":"pinostrobin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/boesenbergia-pandurata","display_name":"Boesenbergia pandurata","score":0.8960000276565552},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8579999804496765},{"id":"https://openalex.org/keywords/estrogen-receptor-alpha","display_name":"estrogen receptor alpha","score":0.9309999942779541},{"id":"https://openalex.org/keywords/anti-breast-cancer-agents","display_name":"anti-breast cancer agents","score":0.8389999866485596},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6100000143051147},{"id":"https://openalex.org/keywords/admet-prediction","display_name":"ADMET prediction","score":0.8100000023841858},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7540000081062317},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.8489999771118164},{"id":"https://openalex.org/keywords/mm-gbsa-binding-free-energy","display_name":"MM-GBSA binding free energy","score":0.8479999899864197},{"id":"https://openalex.org/keywords/drug-derivatives","display_name":"drug derivatives","score":0.3440000116825104}],"concepts":[{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.8254799842834473},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.7101265788078308},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5373560190200806},{"id":"https://openalex.org/C2910080358","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Oestrogen receptor","level":4,"score":0.5330575704574585},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5322028994560242},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.48483550548553467},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.450234979391098},{"id":"https://openalex.org/C172313692","wikidata":"https://www.wikidata.org/wiki/Q14902310","display_name":"Estrogen receptor alpha","level":5,"score":0.44070667028427124},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4093875288963318},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3674686551094055},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3152320384979248},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.2949942648410797},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25002801418304443},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22900253534317017},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22440800070762634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15356752276420593},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.04546308517456055},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.46542/pe.2024.243.5156","doi":"https://doi.org/10.46542/pe.2024.243.5156","is_oa":true,"landing_page_url":"http://dx.doi.org/10.46542/pe.2024.243.5156","pdf_url":null,"source":{"id":"https://openalex.org/S151451544","display_name":"Pharmacy Education","issn_l":"1560-2214","issn":["1560-2214","1477-2701"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacy Education","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.46542/pe.2024.243.5156","doi":"https://doi.org/10.46542/pe.2024.243.5156","is_oa":true,"landing_page_url":"http://dx.doi.org/10.46542/pe.2024.243.5156","pdf_url":null,"source":{"id":"https://openalex.org/S151451544","display_name":"Pharmacy Education","issn_l":"1560-2214","issn":["1560-2214","1477-2701"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacy Education","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1603231983","https://openalex.org/W2009867031","https://openalex.org/W2131239427","https://openalex.org/W2152449875","https://openalex.org/W2781664750","https://openalex.org/W2889646458","https://openalex.org/W2910066590","https://openalex.org/W3011987578","https://openalex.org/W3015165610","https://openalex.org/W3032956014","https://openalex.org/W3046124653","https://openalex.org/W3118761007","https://openalex.org/W3197831413","https://openalex.org/W4200386731","https://openalex.org/W4310810352","https://openalex.org/W4327625867","https://openalex.org/W4382684117"],"related_works":["https://openalex.org/W7134129308","https://openalex.org/W4406576233","https://openalex.org/W4396615543","https://openalex.org/W4396568916","https://openalex.org/W4310810352","https://openalex.org/W7171287689","https://openalex.org/W4391283125","https://openalex.org/W3000821736","https://openalex.org/W2971472978","https://openalex.org/W4402487895"],"abstract_inverted_index":{"Background:":[0],"Breast":[1],"cancer":[2,8,29,71,199],"is":[3,14],"the":[4,19,25,42,62,89,97,101,160,171,194,202],"main":[5],"cause":[6],"of":[7,24,44,64,94,100,155,187],"death":[9],"among":[10],"women.":[11],"The":[12,83,92],"issue":[13],"more":[15,54,145],"complex":[16],"due":[17],"to":[18,60,87,148],"side":[20],"effects":[21],"and":[22,52,66,117,133],"resistance":[23],"currently":[26],"used":[27,111,121],"breast":[28],"drugs.":[30],"Pinostrobin,":[31],"a":[32,178,182],"compound":[33],"found":[34],"in":[35,79,159],"Boesenbergia":[36],"pandurata,":[37],"has":[38,193],"anticancer":[39],"activity.":[40],"Modifying":[41],"structure":[43],"pinostrobin":[45,65,175],"can":[46],"improve":[47],"drug":[48],"bioavailability,":[49],"reduce":[50],"toxicity,":[51],"work":[53],"selectively.":[55],"Objective:":[56],"This":[57],"study":[58],"aimed":[59],"predict":[61,88],"potentials":[63],"its":[67],"derivatives":[68],"as":[69,196],"anti-breast":[70,198],"agents":[72],"against":[73],"human":[74,102,203],"oestrogen":[75,103,204],"receptors":[76],"by":[77,170],"an":[78,197],"silico":[80],"approach.":[81],"Methods:":[82],"pkCSM":[84],"was":[85,110,119,134,144],"utilised":[86],"ADMET":[90],"characteristics.":[91],"interaction":[93,161,180],"ligands":[95],"with":[96,106,150,181],"binding":[98,151],"site":[99],"receptor":[104,205],"alpha":[105],"PDB":[107],"ID":[108],"3ERT":[109],"for":[112,122],"molecular":[113,123,141,167],"docking":[114],"using":[115,164],"MOE,":[116],"AMBER":[118],"then":[120],"dynamic":[124,168],"simulation.":[125],"Results:":[126],"Pinostrobin":[127,191],"pentanoate":[128,176,192],"had":[129,177],"good":[130],"pharmacokinetic":[131],"properties":[132],"neither":[135],"mutagenic":[136],"nor":[137],"hepatotoxic.":[138],"Based":[139],"on":[140],"docking,":[142],"it":[143],"potent":[146],"compared":[147],"pinostrobin,":[149],"free":[152],"energy":[153,185],"values":[154],"-7.849":[156],"kcal/mol.":[157,189],"Furthermore,":[158],"stability":[162],"evaluation":[163],"100":[165],"ns":[166],"simulation":[169],"MM-GBSA":[172],"calculation":[173],"method,":[174],"stable":[179],"total":[183],"bond":[184],"value":[186],"-9.943":[188],"Conclusion:":[190],"potential":[195],"alternative":[200],"through":[201],"alpha.":[206]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4396554064","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2024-05-02T00:00:00"}
